VX-661/Ivacaftor

ivacaftor · Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VX-661/Ivacaftor, covering 2018-07-27 to 2019-12-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of VX-661/Ivacaftor in Pediatric Subjects With Cystic Fibrosis (CF) [Phase 3]

See pricing